The State of the Art: Atrial Fibrillation Epidemiology, Prevention, and Treatment Article

Full Text via DOI: 10.1016/j.mayocp.2016.08.022 PMID: 27825618 Web of Science: 000389539500017

Cited authors

  • Morin, Daniel P.; Bernard, Michael L.; Madias, Christopher; Rogers, Paul A.; Thihalolipavan, Sudarone; Estes, N. A. Mark, III


  • As the most common sustained arrhythmia in adults, atrial fibrillation (AF) is an established and growing epidemic. To provide optimal patient care, it is important for clinicians to be aware of AF's epidemiological trends, methods of risk reduction, and the various available treatment modalities. Our understanding of AF's pathophysiology has advanced, and with this new understanding has come advancements in prevention strategies as well as pharmacological and nonpharmacological treatment options. Following PubMed and MEDLINE searches for AF risk factors, epidemiology, and therapies, we reviewed relevant articles (and bibliographies of those articles) published from 2000 to 2016. This "state-of-the-art" review provides a comprehensive update on the understanding of AF in the world today, contemporary therapeutic options, and directions of ongoing and future study. (C) 2016 Mayo Foundation for Medical Education and Research

Publication date

  • 2016

Published in

International Standard Serial Number (ISSN)

  • 0025-6196

Start page

  • 1778

End page

  • 1810


  • 91


  • 12